Pharmabiz14h
Mineralys Therapeutics gets US FDA nod to begin phase 2 trial of lorundrostat for OSA in patients with hypertension
Radnor, Pennsylvania Friday, January 10, 2025, 18:00 Hrs [IST] ...
Pharmabiz15h
Zuellig Pharma becomes STADA Philippines’ exclusive distribution partner
Zuellig Pharma becomes STADA Philippines’ exclusive distribution partner: Manila, Philippines Friday, January 10, 2025, 17:00 Hrs [IST] Zuellig Pharma, a leading healthcare solu ...
Pharmabiz16h
IGC Pharma names IGC-AD1 phase 2 clinical trial for Alzheimer’s agitation as CALMA trial
IGC Pharma names IGC-AD1 phase 2 clinical trial for Alzheimer’s agitation as CALMA trial: Potomac, Maryland Friday, January 10, 2025, 16:30 Hrs [IST] IGC Pharma, Inc, an AI-powe ...
Pharmabiz16h
AI to revolutionise hair loss diagnosis and treatment, say experts
AI to revolutionise hair loss diagnosis and treatment, say experts: Our Bureau, New Delhi Friday, January 10, 2025, 16:20 Hrs [IST] The integration of AI marks a significant leap ...
Pharmabiz16h
Impose 5-15% duty on imports of medical devices and monitor MRP against import landed cost, demands AiMeD
Our Bureau, New Delhi Friday, January 10, 2025, 16:10 Hrs [IST] ...
Pharmabiz16h
Samsung Biologics extends collaboration with LigaChem Biosciences for ADC development
Samsung Biologics extends collaboration with LigaChem Biosciences for ADC development: Incheon, S. Korea Friday, January 10, 2025, 16:00 Hrs [IST] Samsung Biologics, a global cont ...
Pharmabiz16h
Medi Assist’s 2024 findings shed light on rising costs, incidence and demography wise hospitalisation patterns
Our Bureau, Mumbai Friday, January 10, 2025, 15:40 Hrs [IST] ...
Pharmabiz17h
Biocon Biologics to present at the 43rd annual J P Morgan Healthcare Conference
Biocon Biologics to present at the 43rd annual J P Morgan Healthcare Conference: Our Bureau, Bengaluru Friday, January 10, 2025, 15:10 Hrs [IST] Biocon Biologics, a fully integrat ...
Pharmabiz17h
Sanofi announces new Sarclisa subcutaneous formulation meets co-primary endpoints in IRAKLIA phase 3 study in multiple myeloma
Sanofi announces new Sarclisa subcutaneous formulation meets co-primary endpoints in IRAKLIA phase 3 study in multiple myeloma: Paris Friday, January 10, 2025, 15:00 Hrs [IST] Res ...
Pharmabiz17h
Dr Sunita Tandulwadkar takes over as 63rd FOGSI president, unveils bold vision for transforming women’s healthcare in India
Our Bureau, Mumbai Friday, January 10, 2025, 14:45 Hrs [IST] ...
Pharmabiz18h
Clarivate identifies eleven potential blockbuster and transformative drugs in annual Drugs to Watch report
Clarivate identifies eleven potential blockbuster and transformative drugs in annual Drugs to Watch report: London, UK Friday, January 10, 2025, 14:00 Hrs [IST] Clarivate Plc, a l ...
Pharmabiz19h
Persistent Systems introduces Pi-OmniKG with Google Cloud
Persistent Systems, a global leader in digital engineering and enterprise modernization, announced the launch of Pi-OmniKG, an advanced AI-driven knowledge graph solution developed with Google Cloud ...